Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

BACKGROUND: In four randomized, controlled, European trials, dienogest 2 mg once daily demonstrated significant efficacy for lesion reduction and reduction in pain intensity in endometriosis. We describe a pooled analysis of the safety and tolerability data from these trials to confirm and further c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Womens Health
Päätekijät: Strowitzki, Thomas, Faustmann, Thomas, Gerlinger, Christoph, Schumacher, Ulrike, Ahlers, Christiane, Seitz, Christian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4403681/
https://ncbi.nlm.nih.gov/pubmed/25926759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S77202
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia